Pasar al contenido principal

ESTUDIO DE LOS MECANISMOS MOLECULARES IMPLICADOS EN LA DIVERSIDAD Y ESTABILIDAD DE LAS CEPAS PRIONICAS

AGL2015-65046-C2-1-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies

  • Eraña, Hasier
  • Charco, Jorge M.
  • Di Bar, Michele A.
  • Díaz-Domínguez, Carlos M.
  • López-Moreno, Rafael
  • Vidal, Enric
  • González-Miranda, Ezequiel
  • Pérez-Castro, Miguel A.
  • García-Martínez, Sandra
  • Bravo, Susana
  • Fernández-Borges, Natalia
  • Geijo, Mariví
  • D’Agostino, Claudia
  • Garrido, Joseba
  • Bian, Jifeng
  • König, Anna
  • Uluca-Yazgi, Boran
  • Sabate, Raimon
  • Khaychuk, Vadim
  • Vanni, Ilaria
  • Telling, Glenn C.
  • Heise, Henrike
  • Nonno, Romolo
  • Requena, Jesús R.
  • Castilla, Joaquín
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis

  • Sevillano, Alejandro M.
  • Fernández-Borges, Natalia
  • Younas, Neelam
  • Wang, Fei
  • Elezgarai, Saioa R.
  • Bravo, Susana
  • Vázquez-Fernández, Ester
  • Rosa, Isaac
  • Eraña, Hasier
  • Gil, David
  • Veiga, Sonia
  • Vidal, Enric
  • Erickson-Beltran, Melissa L.
  • Requena, Jesús R.
Very solid evidence suggests that the core of full length PrPSc is a 4-rung β-solenoid, and that individual PrPSc subunits stack to form amyloid fibers. We recently used limited proteolysis to map the β-strands and connecting loops that make up the PrPSc solenoid. Using high resolution SDS-PAGE followed by epitope analysis, and mass spectrometry, we identified positions ~116/118, 133–134, 141, 152–153, 162, 169 and 179 (murine numbering) as Proteinase K (PK) cleavage sites in PrPSc. Such sites likely define loops and/or borders of β-strands, helping us to predict the threading of the β-solenoid. We have now extended this approach to recombinant PrPSc (recPrPSc). The term recPrPSc refers to bona fide recombinant prions prepared by PMCA, exhibiting infectivity with attack rates of ~100%. Limited proteolysis of mouse and bank vole recPrPSc species yielded N-terminally truncated PK-resistant fragments similar to those seen in brain-derived PrPSc, albeit with varying relative yields. Along with these fragments, doubly N- and C-terminally truncated fragments, in particular ~89/97-152, were detected in some recPrPSc preparations; similar fragments are characteristic of atypical strains of brain-derived PrPSc. Our results suggest a shared architecture of recPrPSc and brain PrPSc prions. The observed differences, in particular the distinct yields of specific PK-resistant fragments, are likely due to differences in threading which result in the specific biochemical characteristics of recPrPSc. Furthermore, recombinant PrPSc offers exciting opportunities for structural studies unachievable with brain-derived PrPSc., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dogs are resistant to prion infection, due to the presence of aspartic or glutamic acid at position 163 of their prion protein

  • Vidal, Enric
  • Fernández-Borges, Natalia
  • Eraña, Hasier
  • Parra, Beatriz
  • Pintado, Belén
  • Sánchez-Martín, Manuel A.
  • Charco, Jorge M.
  • Ordóñez, Montserrat
  • Pérez-Castro, Miguel A.
  • Pumarola, Martí
  • Mathiason, Candace K.
  • Mayoral, Tomás
  • Castilla, Joaquín
Unlike other species, prion disease has never been described in dogs even though they were similarly exposed to the bovine spongiform encephalopathy (BSE) agent. This resistance prompted a thorough analysis of the canine PRNP gene and the presence of a negatively charged amino acid residue in position 163 was readily identified as potentially fundamental as it differed from all known susceptible species. In the present study, the first transgenic mouse model expressing dog prion protein (PrP) was generated and challenged intracerebrally with a panel of prion isolates, none of which could infect them. The brains of these mice were subjected to in vitro prion amplification and failed to find even minimal amounts of misfolded prions providing definitive experimental evidence that dogs are resistant to prion disease. Subsequently, a second transgenic model was generated in which aspartic acid in position 163 was substituted for asparagine (the most common in prion susceptible species) resulting in susceptibility to BSE‐derived isolates. These findings strongly support the hypothesis that the amino acid residue at position 163 of canine cellular prion protein (PrPC) is a major determinant of the exceptional resistance of the canidae family to prion infection and establish this as a promising therapeutic target for prion diseases., MINECO/FEDER. Grant Numbers: AGL2015‐65046‐C2‐1‐R, AGL2008‐05296‐C02 Interreg. Grant Number: POCTEFA EFA148/16
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

An amino acid substitution found in animals with low susceptibility to prion diseases confers a protective dominant-negative effect in prion-infected transgenic mice

  • Otero García, Alicia
  • Bolea Bailo, Rosa
  • Hedman Altamirano, Carlos
  • Fernández-Borges, Natalia
  • Marín González, María Belén
  • López Pérez, Óscar
  • Barrio Alegre, Tomás
  • Eraña, Hasier
  • Sánchez-Martín, Manuel A.
  • Monzón Garcés, Marta
  • Badiola Díez, Juan José
  • Castilla, Joaquín
While prion diseases have been described in numerous species, some, including those of the Canidae family, appear to show resistance or reduced susceptibility. A better understanding of the factors underlying prion susceptibility is crucial for the development of effective treatment and control measures. We recently demonstrated resistance to prion infection in mice overexpressing a mutated prion protein (PrP) carrying a specific amino acid substitution characteristic of canids. Here, we show that coexpression of this mutated PrP and wild-type mouse PrP in transgenic mice inoculated with different mouse-adapted prion strains (22 L, ME7, RML, and 301C) significantly increases survival times (by 45 to 113%). These data indicate that this amino acid substitution confers a dominant-negative effect on PrP, attenuating the conversion of PrPC to PrPSc and delaying disease onset without altering the neuropathological properties of the prion strains. Taken together, these findings have important implications for the development of new treatment approaches for prion diseases based on dominant-negative proteins.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models

  • Otero, A.
  • Hedman, C.
  • Fernández-Borges, N.
  • Eraña, H.
  • Marín, B.
  • Monzón, M.
  • Sánchez-Martín, M.A.
  • Nonno, R.
  • Badiola, J.J.
  • Bolea, R.
  • Castilla, J.
Specific variations in the amino acid sequence of prion protein (PrP) are key determinants of susceptibility to prion diseases. We previously showed that an amino acid substitution specific to canids confers resistance to prion diseases when expressed in mice and demonstrated its dominant-negative protective effect against a variety of infectious prion strains of different origins and characteristics. Here, we show that expression of this single amino acid change significantly increases survival time in transgenic mice expressing bank vole cellular prion protein (PrP C ), which is inherently prone to misfolding, following inoculation with two distinct prion strains (the CWD-vole strain and an atypical strain of spontaneous origin). This amino acid substitution hinders the propagation of both prion strains, even when expressed in the context of a PrP C uniquely susceptible to a wide range of prion isolates. Non-inoculated mice expressing this substitution experience spontaneous prion formation, but showing an increase in survival time comparable to that observed in mutant mice inoculated with the atypical strain. Our results underscore the importance of this PrP variant in the search for molecules with therapeutic potential against prion diseases.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis

  • Sevillano, Alejandro M.
  • Fernández-Borges, Natalia
  • Younas, Neelam
  • Wang, Fei
  • Elezgarai, Saioa R.
  • Bravo, Susana
  • Vázquez-Fernández, Ester
  • Rosa, Isaac
  • Eraña, Hasier
  • Gil, David
  • Veiga, Sonia
  • Vidal, Enric
  • Erickson-Beltran, Melissa L.
  • Requena, Jesús R.
Very solid evidence suggests that the core of full length PrPSc is a 4-rung β-solenoid, and that individual PrPSc subunits stack to form amyloid fibers. We recently used limited proteolysis to map the β-strands and connecting loops that make up the PrPSc solenoid. Using high resolution SDS-PAGE followed by epitope analysis, and mass spectrometry, we identified positions ~116/118, 133–134, 141, 152–153, 162, 169 and 179 (murine numbering) as Proteinase K (PK) cleavage sites in PrPSc. Such sites likely define loops and/or borders of β-strands, helping us to predict the threading of the β-solenoid. We have now extended this approach to recombinant PrPSc (recPrPSc). The term recPrPSc refers to bona fide recombinant prions prepared by PMCA, exhibiting infectivity with attack rates of ~100%. Limited proteolysis of mouse and bank vole recPrPSc species yielded N-terminally truncated PK-resistant fragments similar to those seen in brain-derived PrPSc, albeit with varying relative yields. Along with these fragments, doubly N- and C-terminally truncated fragments, in particular ~89/97-152, were detected in some recPrPSc preparations; similar fragments are characteristic of atypical strains of brain-derived PrPSc. Our results suggest a shared architecture of recPrPSc and brain PrPSc prions. The observed differences, in particular the distinct yields of specific PK-resistant fragments, are likely due to differences in threading which result in the specific biochemical characteristics of recPrPSc. Furthermore, recombinant PrPSc offers exciting opportunities for structural studies unachievable with brain-derived PrPSc., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies

  • Eraña, Hasier
  • Charco, Jorge M.
  • Di Bar, Michele A.
  • Díaz-Domínguez, Carlos M.
  • López-Moreno, Rafael
  • Vidal, Enric
  • González-Miranda, Ezequiel
  • Pérez-Castro, Miguel A.
  • García-Martínez, Sandra
  • Bravo, Susana
  • Fernández-Borges, Natalia
  • Geijo, Mariví
  • D’Agostino, Claudia
  • Garrido, Joseba
  • Bian, Jifeng
  • König, Anna
  • Uluca-Yazgi, Boran
  • Sabate, Raimon
  • Khaychuk, Vadim
  • Vanni, Ilaria
  • Telling, Glenn C.
  • Heise, Henrike
  • Nonno, Romolo
  • Requena, Jesús R.
  • Castilla, Joaquín
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies

  • Eraña, Hasier|||0000-0001-8776-4211
  • Charco, Jorge M.|||0000-0003-3476-1855
  • Di Bari, Michele Angelo|||0000-0003-0943-6823
  • Díaz-Domínguez, Carlos M.|||0000-0002-0410-1963
  • López-Moreno, R.
  • Vidal Barba, Enric|||0000-0002-4965-3286
  • González-Miranda, E.
  • Pérez-Castro, Miguel A.|||0000-0003-2850-3470
  • García-Martínez, Sandra|||0000-0002-6910-9202
  • Bravo Lopez, Susana Belén|||0000-0001-7615-3079
  • Fernández-Borges, Natalia
  • Geijo, Maria V.|||0000-0002-3120-1038
  • D'Agostino, C.
  • Garrido, Joseba M.
  • Bian, J.
  • König, A.
  • Uluca-Yazgi, B.
  • Sabate, R.
  • Khaychuk, V.
  • Vanni, Ilaria|||0000-0003-2617-4263
  • Telling, G. C.
  • Heise, Henrike|||0000-0002-9081-3894
  • Nonno, Romolo|||0000-0001-7556-1564
  • Requena, Jesús R.
  • Castilla, Joaquín|||0000-0002-2216-1361
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unraveling the key to the resistance of canids to prion diseases

  • Fernández-Borges, Natalia
  • Parra, Beatriz|||0000-0002-5371-7449
  • Vidal Barba, Enric|||0000-0002-4965-3286
  • Eraña, Hasier|||0000-0001-8776-4211
  • Sánchez-Martín, Manuel A.|||0000-0001-8370-1336
  • de Castro, Jorge|||0000-0002-2380-8956
  • Elezgarai, Saioa R.|||0000-0001-7054-9689
  • Pumarola i Batlle, Martí|||0000-0002-0935-7941
  • Mayoral, Tomás|||0000-0003-2644-1966
  • Castilla, Joaquín|||0000-0002-2216-1361
One of the characteristics of prions is their ability to infect some species but not others and prion resistant species have been of special interest because of their potential in deciphering the determinants for susceptibility. Previously, we developed different in vitro and in vivo models to assess the susceptibility of species that were erroneously considered resistant to prion infection, such as members of the Leporidae and Equidae families. Here we undertake in vitro and in vivo approaches to understand the unresolved low prion susceptibility of canids. Studies based on the amino acid sequence of the canine prion protein (PrP), together with a structural analysis in silico, identified unique key amino acids whose characteristics could orchestrate its high resistance to prion disease. Cell- and brain-based PMCA studies were performed highlighting the relevance of the D163 amino acid in proneness to protein misfolding. This was also investigated by the generation of a novel transgenic mouse model carrying this substitution and these mice showed complete resistance to disease despite intracerebral challenge with three different mouse prion strains (RML, 22L and 301C) known to cause disease in wild-type mice. These findings suggest that dog D163 amino acid is primarily, if not totally, responsible for the prion resistance of canids. Detection of individuals or whole species resistant to any infectious disease is vital to understand the determinants of susceptibility and to develop appropriate therapeutic and preventative strategies. Canids have long been considered resistant to prion infection given the absence of clinical disease despite exposure to the causal agent. Through extensive analysis of the canine prion protein we have detected a key amino acid that might be responsible for their universal resistance to prion disease. Using in vitro and in vivo models we demonstrated that the presence of this residue confers resistance to prion infection when introduced to susceptible animals, opening the way to develop a new therapeutic approach against these, at present, untreatable disorders.